Evelo Biosciences Inc (EVLO)
0.0406
-0.01
(-17.14%)
USD |
OTCM |
May 17, 15:57
Evelo Biosciences Total Liabilities (Quarterly): 47.33M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 47.33M |
| June 30, 2023 | 66.94M |
| March 31, 2023 | 69.36M |
| December 31, 2022 | 69.43M |
| September 30, 2022 | 77.00M |
| June 30, 2022 | 76.25M |
| March 31, 2022 | 75.63M |
| December 31, 2021 | 79.20M |
| September 30, 2021 | 83.38M |
| June 30, 2021 | 82.96M |
| March 31, 2021 | 65.20M |
| December 31, 2020 | 60.15M |
| Date | Value |
|---|---|
| September 30, 2020 | 54.41M |
| June 30, 2020 | 44.70M |
| March 31, 2020 | 43.80M |
| December 31, 2019 | 30.72M |
| September 30, 2019 | 30.59M |
| June 30, 2019 | 26.12M |
| March 31, 2019 | 23.05M |
| December 31, 2018 | 22.92M |
| September 30, 2018 | 24.85M |
| June 30, 2018 | 23.24M |
| March 31, 2018 | 21.06M |
| December 31, 2017 | 14.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
26.12M
Minimum
Jun 2019
83.38M
Maximum
Sep 2021
60.18M
Average
66.07M
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 48.40M |
| Electromed Inc | 6.357M |
| Xtant Medical Holdings Inc | 46.25M |
| Asensus Surgical Inc | 27.79M |
| Myomo Inc | 5.621M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.63M |
| Shareholders Equity (Quarterly) | -26.71M |